Wellbeing Management
Clinical Trials Management
Change Management & Mentoring
Life Coaching
Sustainable Impact Modeling
On-demand Formulation Development
Regulatory Compliance Services

BLYMUM is an Italian company based in Milan providing services, products and knowledge for those Companies specialized in developing, producing and marketing food supplements, functional foods, novel foods, nutraceuticals, cosmetics and medical devices, and for those Companies strategically focused on social and workplace sustainability.

Blymum supports explicitly the Sustainable Development Goals of the United Nations. 
Our mission is to contribute to people’s health, physical and psychological wellbeing, longevity and beauty. 

BLYMUM offers professional support to Pharmaceutical, Food, Healthcare and other Clients in the following areas: Clinical Trials Management; Regulatory Compliance; Wellbeing Management; Sustainable Impact Modeling; Change Management & Mentoring.

In parallel, we are directly involved in product innovation processes. The BLYMUM distinctive feature lies in the development of Physiological Modulators, that are scientifically proven solutions for specific human psycho-physical problems, pathological phenomena and adverse living and working conditions: BLYMUM Food Supplements; On-demand Formulation Development.

Both within our personal mentoring and selected business services, we apply the distinctive methodology and philosophy to self management, life habits correction, health and wellbeing improvement.
It's mindset, structured and customized under the brand Livella®, is inspired by the physiological balance management  of the human organism.

Regulation (EU) no. 536/2014 on Clinical Trials
After the transition period, from today's date 31 January 2023 all the authorization procedures for clinical trials must compulsorily be requested following the contents of the new...
read more
Market Surveillance of Medical Devices
All manufacturers of medical devices (MDs) must minimize the risk posed by their MDs and ensure patient safety. Post-market surveillance is thus mandatory. According to the new MDR...
read more